The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Suicide

In brief

The BRAVO study seeks to determine if dietary supplementation with omega-3 highly unsaturated fatty acids (omega-3 HUFAs) reduces the risk for serious suicidal behaviors, suicidal thinking, negative emotions, and symptoms associated with suicide risk, in a Veteran and non-Veteran population that is at risk for suicidal behaviors. This study seeks to evaluate the efficacy of omega-3 HUFAs among a representative population of US Veterans and non-Veterans already receiving appropriate medical care so that if successful, these results can be readily applied to broader populations in the US.

Key facts

Study ID
NCT01901887
Run by
Medical University of South Carolina
People needed
125
Starts
2014-03-01
Expected to finish
2016-08-30
Last updated by the study team
2018-06-12

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.